- Prof John Savill (MRC) need intelligent, stratified experimental medicine for dementia therapies #G8dementia
- RT @MRCTechnology: Scientist with potential dementia target? Pre-register at http://t.co/184SdfkCAV £3m funding to advance dementia resea…
- RT @CSO_Scotland: CSO hosting workshop on Enhancing strategic approach to public involvement in research - partnership with patients a key …
- RT @LIFECorporation: Second Deputy Premier Prince Muqrin speaks to the media following the launch of the Saudi Human Genome Program: http:/…
- RT @AmyatDH: Prof. Simon Lovestone: we need big cohorts - people ready to take part in trials, w/ bio markers & to do that in extreme colla…
- RT @JNJInnovation: JANSSEN's Mike Krams calls for. Global Declaration and global coordination @ #G8dementia
- RT @AmyatDH: Janssen: we have to seize the moment - calls on governments to categorise dementia in same way as HIV, bird flu etc #G8dementia
- #G8dementia Prof John Savill need to share data across borders using Safe Havens but EU Data Protection laws may have negative effect
- RT @AlzheimerEurope: Patient involvement, biomarkers and effective regulatory pathways for medicines are some of the keys to success, says …
- RT @AnnaHepburnDH: Andrea Ponti, @jpmorgan: far too many examples of drugs languishing somewhere in the development phase
- RT @TrialReach: Andrea Ponti: the risk and rewards need to be re-balanced in dementia drug research #G8dementia
- See live video stream of #G8Dementia http://t.co/2TyrCQOb6A discussion around Big Data at the moment
- With the Christmas/New Year Holidays are almost upon us we wanted to ensure you are aware these calls for proposals. http://t.co/a9lzYSLOEf
- Scottish life sciences research among world's best http://t.co/35JjUrNlVX
- Watch the G8 dementia summit live on 11 December https://t.co/IMBTVfaS9V
Scottish Centre For Regenerative Medicine
The goal of the Scottish Centre for Regenerative Medicine is to generate a new class of medicines that promote repair and which, taken together with conventional medicines, will enable physicians to both treat cause and reverse damage. To enable this, the Scottish Government and the University of Edinburgh have jointly invested over £600m in a new Centre purpose built for stem cell biology and medicine. In addition to 3,500 sqm of laboratory space and state of the art tissue culture facilities, the building contains imaging and small animal surgery facilities, a 7 room cGMP facility suitable for ATMP work alongside an academic cell therapy unit.
The centre brings together two scientific groups – stem cell biologists of the internationally-leading Institute of Stem Cell Research and clinical academics working on regeneration in liver, blood and brain – with scientists expert in the derivation and manufacture cells at cGMP grade working with the Scottish National Blood Transfusion Service and a not-for-profit company Roslin Cells.
The excellence of this innovative development has already been recognised by the award of MRC Centre status. The resulting community, already more than 150 strong and growing is uniquely placed to collaborate with industry in the discovery and delivery of novel therapies in regenerative medicine.